Bristol-Myers Squibb
BMY
#175
Rank
A$182.18 B
Marketcap
A$89.13
Share price
2.13%
Change (1 day)
37.60%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): A$6.66

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is A$6.45. In 2025 the company made an earnings per share (EPS) of A$4.92 an increase over its 2024 EPS that were of A-$6.28.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$6.6635.44%
2025A$4.92-178.28%
2024A-$6.28-213.92%
2023A$5.5230.2%
2022A$4.24-6.04%
2021A$4.51-179.29%
2020A-$5.69-281.37%
2019A$3.14-27.21%
2018A$4.31
2016A$3.80175.26%
2015A$1.38-19.83%
2014A$1.72-22.44%
2013A$2.2234.48%
2012A$1.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.41 92.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.47 46.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.08-83.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$5.08-21.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$42.48 558.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$23.06 257.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.71-58.09%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$8.07 25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.80-72.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$9.50 47.14%๐Ÿ‡ฌ๐Ÿ‡ง UK